CG Oncology, Inc. Balance Sheet
CGON / Health Care|3 years of annual SEC 10-K data (FY2023-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
CG Oncology, Inc. had $792M in total assets and $753M in shareholders' equity as of FY2025. Total debt was $3M against $32M in cash, resulting in a $29M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash & Equivalents | $32.5M | $257.1M | $8.3M |
| Inventory | $1.6M | $0 | - |
| Current Assets | $759.5M | $754.2M | $194.1M |
| PP&E (Net) | $15.6M | $272.0K | $69.0K |
| Goodwill | $10.3M | $0 | - |
| Total Assets | $791.6M | $754.8M | $199.3M |
| Current Liabilities | $30.8M | $21.4M | $14.3M |
| Total Debt | $3.0M | $0 | - |
| Shareholders' Equity | $752.6M | $733.4M | -$123.1M |